A fresh round of sideways trading continues for Agios Pharmaceuticals Inc (AGIO) Stock.
Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]
With upside potential, Agios Pharmaceuticals Inc (AGIO) Stock is well-positioned to grow
Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]
In the current cycle, Agios Pharmaceuticals Inc (AGIO) Stock is showing signs of growth
Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]
Agios Pharmaceuticals Inc (AGIO) Stock is the one stock you should own forever
Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]
How Agios Pharmaceuticals Inc (AGIO) Stock converts water flow into cash flow
Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]
Cantor Fitzgerald Assigned “an Overweight” Rating to Agios Pharmaceuticals Inc (NASDAQ:AGIO) Stock
Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]
